(No ratings)
Dr. Andromachi Scaradavou, MD is an oncologist in New York, NY specializing in oncology (cancer care). She graduated from University of Athens Faculty of Medicine. Dr. Andromachi Scaradavou, MD is affiliated with Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center.
1275 York Avenue Between 67th and 68th Streets
New York, NY 10065
Dr. Andromachi Scaradavou, MD graduated from University of Athens Faculty of Medicine. She completed residency at Massachusetts General Hospital. She is certified by the Board Certification: Pediatarics and has a state license in New York.
Medical School: University of Athens Faculty of Medicine
Residency: Massachusetts General Hospital
Board Certification: Board Certification: Pediatarics
Licensed In: New York
Dr. Andromachi Scaradavou, MD is associated with these hospitals and organizations:
Dr. Andromachi Scaradavou, MD appears to accept the following insurance providers: Magnacare, Carrum Health, Non-Participating Plans with Out of Network Benefits, Blue Cross Blue Shield New York, UMR, MVP, Emblem Essential, Husky CT Medicaid, Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO), NYC Medicare Advantage Plus for City Employees, World Trade Center Health Program (WTC), Emblem Medicare Advantage, Oscar, First Health, Qualcare, Horizon Medicare Advantage, Aetna, Blue Cross Health Plus, Emblem, Healthfirst, Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan), Blue Cross Blue Shield states outside of NY/NJ, Tricare, Healthfirst Managed Medicaid, Fidelis, Multiplan/Beech Street/PHCS, Aetna Medicare Advantage (City of NY retirees only, starting 9/1/23), United Healthcare, Medicare Part A&B (traditional Medicare), Horizon Blue Cross Blue Shield New Jersey (PPO), Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO), Blue Cross Blue Shield Federal Employee Program, Connecticare, Oxford, Straight NJ Medicaid, Horizon Blue Cross Blue Shield New Jersey (HMO), Healthsmart, Empire Essential, Straight NY Medicaid, Healthfirst Medicare Advantage, Fidelis Medicare Advantage, Cigna, Empire Blue Cross Medicare Advantage and Fidelis Managed Medicaid & HARP.
According to our sources, Dr. Andromachi Scaradavou, MD accepts the following insurance providers:
Dr. Andromachi Scaradavou, MD does not have any reviews yet, be the first to leave a review of Dr. Andromachi Scaradavou, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Andromachi Scaradavou, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Novartis Pharmaceuticals Corporation |
$203
HSC835 $106 |
KYMRIAH $97 |
---|---|---|
MEDEXUS PHARMA, INC. |
$168
$168 |
|
Alexion Pharmaceuticals, Inc. |
$117
SOLIRIS $117 |
Food and Beverage | $488 |
---|
Dr. Andromachi Scaradavou, MD has received 2 research payments totaling $2,100.
Dr. Andromachi Scaradavou is an oncology (cancer care) and general pediatrics specialist in New York, NY. Before completing her residency at Massachusetts General Hospital and a hospital affiliated with Harvard Medical School, Dr. Scaradavou attended medical school at the University of Athens Faculty of Medicine. She is affiliated with Memorial Sloan Kettering Cancer Center. Her practice in New York, NY is open to new patients as reported by Yext.